NorthView Acquisition Corporation
Status: Live Deal
U=S+W/2+R
W=S@11.50
R=S/10
IPO Proceeds, $M | $189.75M |
---|---|
IPO Date | Dec 20, 2021 |
CEO | Jack Stover |
Left Lead | I-Bankers Securities |
IPO Cash in Trust | 101.0% |
SPAC Tenor | 15 + 9 + 3 + 6 + 6 |
IPO Sector | Healthcare ▶ |
IPO Geography | Global |
Target Company | Profusa |
Deal Announced | Nov 7, 2022 |
Deal Size, $M | $270.10M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings |
www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Mar 21, 2025 |
NVAC
NVACU
NVACW
NVACR
Price | $12.10 |
---|---|
Last closing price | $12.10 |
H/L, today | $12.09 / $12.10 |
H/L, 52-week | $9.95 / $10.85 |
Volume, today | 1 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.